These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 11158002)

  • 1. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance.
    Vgontzas AN; Legro RS; Bixler EO; Grayev A; Kales A; Chrousos GP
    J Clin Endocrinol Metab; 2001 Feb; 86(2):517-20. PubMed ID: 11158002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep apnea is a manifestation of the metabolic syndrome.
    Vgontzas AN; Bixler EO; Chrousos GP
    Sleep Med Rev; 2005 Jun; 9(3):211-24. PubMed ID: 15893251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.
    Vgontzas AN; Trakada G; Bixler EO; Lin HM; Pejovic S; Zoumakis E; Chrousos GP; Legro RS
    Metabolism; 2006 Aug; 55(8):1076-82. PubMed ID: 16839844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of sleep-disordered breathing on metabolic dysfunctions in patients with polycystic ovary syndrome.
    Chatterjee B; Suri J; Suri JC; Mittal P; Adhikari T
    Sleep Med; 2014 Dec; 15(12):1547-53. PubMed ID: 25311833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance.
    Vgontzas AN; Bixler EO; Chrousos GP
    J Intern Med; 2003 Jul; 254(1):32-44. PubMed ID: 12823641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome.
    Tasali E; Van Cauter E; Ehrmann DA
    J Clin Endocrinol Metab; 2006 Jan; 91(1):36-42. PubMed ID: 16219719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome.
    Fogel RB; Malhotra A; Pillar G; Pittman SD; Dunaif A; White DP
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1175-80. PubMed ID: 11238505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity may be the common pathway for sleep-disordered breathing in women with polycystic ovary syndrome.
    Suri J; Suri JC; Chatterjee B; Mittal P; Adhikari T
    Sleep Med; 2016 Aug; 24():32-39. PubMed ID: 27810183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polycystic ovarian syndrome and obstructive sleep apnea].
    Gateva A; Kamenov Z; Mondeshki Ts; Bilyukov R; Georgiev O
    Akush Ginekol (Sofiia); 2013; 52(3):63-8. PubMed ID: 24283067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
    Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and endocrine status associate with obstructive sleep apnea risk among patients with polycystic ovary syndrome.
    Christ JP; Shinkai K; Corley J; Pasch L; Cedars MI; Huddleston HG
    J Clin Sleep Med; 2024 Jun; 20(6):871-877. PubMed ID: 38217476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
    Paradisi G; Steinberg HO; Shepard MK; Hook G; Baron AD
    J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome.
    Tasali E; Van Cauter E; Hoffman L; Ehrmann DA
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3878-84. PubMed ID: 18647805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance?
    Vgontzas AN
    Arch Physiol Biochem; 2008 Oct; 114(4):211-23. PubMed ID: 18946782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women.
    Mokhlesi B; Scoccia B; Mazzone T; Sam S
    Fertil Steril; 2012 Mar; 97(3):786-91. PubMed ID: 22264851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.